drugset / Trial / NCT01224236

Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants

NCT01224236 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.

Timeline

Start
2010-07
Primary completion
2012-02
Completion
2012-02

Outcome

Missed primary endpoint

paper There was no significant difference in the primary outcome ranking (P = .59) PMID 23339225 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject elemental iron Unknown 2 mg/kg —

Indications